Beyond CRS‐associated analytes, TNB‐383B did not significantly alter chemokine and growth factor production at the tested doses except for near 1500‐fold induction of chemokine interferon gamma‐induced protein 10 (IP10). This evidence concerns the gene CXCL10 and congenital rubella syndrome.